| Impairment of coronary blood flow regulation by endothelium-derived nitric oxide in dogs with alloxan-induced diabetes. | |
| | |
MedLine Citation:
|
PMID: 8797137 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Diabetes mellitus is a major cause of ischemic coronary artery disease. Endothelial dysfunction is implicated in the pathogenesis of diabetic vascular disease. To examine coronary blood flow (CBF) regulation with endothelium-derived nitric oxide (EDNO) in the diabetic state, we compared the effects of both acetylcholine (ACh) and adenosine (Ado) on left circumflex coronary artery (LCX) blood flow in 12 vehicle-treated and 21 dogs made diabetic with alloxan anesthetized with pentobarbital. All dogs were pretreated with aspirin to inhibit endogenous prostaglandins. None of the hemodynamic parameters were significantly different in the two groups. The percent change in coronary vascular resistance (CVR) after ACh (100 ng/kg) infusion was significantly attenuated in diabetic dogs (-56.5 +/- 1.4%) as compared with vehicle-treated dogs (-64.5 +/- 1.2%) (p < 0.01), whereas the effect of Ado (1 microgram/kg) was not different between the two groups (-71.1 +/- 1.5% in vehicle, -67.0 +/- 1.3% in diabetes). After infusion of incremental doses of NG-nitro-L-arginine methyl ester (L-NAME) 10(-5)-10(-3)M, the effect of ACh was progressively inhibited in both groups and was different no longer between the two groups after the maximal dose. L-Arginine (L-ARG), but not D-ARG, significantly restored the effect of ACh in diabetic dogs but did not affect vehicle-treated dogs. The effect of Ado did not change after L- and D-ARG administration. Cu, Zn-superoxide dismutase (Cu, Zn-SOD) had no effect on any of the effects of ACh and Ado in diabetic dogs. Regulation of CBF with EDNO is impaired in dogs with alloxan-induced diabetes, and this impairment is partially restored by L-ARG. |
| | |
Authors:
|
T Matsunaga; K Okumura; H Ishizaka; R Tsunoda; S Tayama; T Tabuchi; H Yasue |
Related Documents
:
|
2253827 - Arrest of glomerulopathy in diabetic dogs by improved glycaemic control. 6371957 - Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenoco... 7128957 - Gut hormone responses in subjects with a permanent ileostomy. 1211067 - 13-norleucine motilin versus pentagastrin: contrasting and competitive effects on gastr... 2840157 - Role of alpha 1- and alpha 2-adrenoceptors in catecholamine-induced hyperglycaemia, lip... 1304577 - Immunomodulation of low dose streptozocin diabetes in mice reveals that insulitis is no... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of cardiovascular pharmacology Volume: 28 ISSN: 0160-2446 ISO Abbreviation: J. Cardiovasc. Pharmacol. Publication Date: 1996 Jul |
Date Detail:
|
Created Date: 1997-01-06 Completed Date: 1997-01-06 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7902492 Medline TA: J Cardiovasc Pharmacol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 60-7 Citation Subset: IM |
Affiliation:
|
Division of Cardiology, Kumamoto University School of Medicine, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetylcholine
/
pharmacology* Adenosine / pharmacology* Alloxan Animals Coronary Vessels / drug effects* Diabetes Mellitus, Experimental / physiopathology* Dogs Dose-Response Relationship, Drug Drug Interactions Endothelium, Vascular / drug effects*, physiology NG-Nitroarginine Methyl Ester / pharmacology* Nitric Oxide / pharmacology Nitric Oxide Synthase / antagonists & inhibitors* Vasodilator Agents / pharmacology* |
| Chemical | |
Reg. No./Substance:
|
0/Vasodilator Agents; 10102-43-9/Nitric Oxide; 50-71-5/Alloxan; 50903-99-6/NG-Nitroarginine Methyl Ester; 51-84-3/Acetylcholine; 58-61-7/Adenosine; EC 1.14.13.39/Nitric Oxide Synthase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electroca...
Next Document: Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coron...